|
⚲
|
| Keyboard |
| Davidow Robert L
✚
|
|
|---|---|
| CIK # | 0002002210 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002002210] | |
| 4 | [0002002210] | |
| SC 13G | [0002002210] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Davidow Robert L | Avenue Therapeutics Inc | [2023-11-28] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Davidow Robert L | |
| Avenue Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Avenue Therapeutics Inc ATXI
Common Stock
|
2023-12-11 | Sell | 128,000 | $0.14 | 17,920 |
|
Avenue Therapeutics Inc ATXI
Common Stock
|
2023-12-11 | Sell | 126,000 | $0.14 | 17,640 |
|
Avenue Therapeutics Inc ATXI
Common Stock
|
2023-12-11 | Sell | 61,000 | $0.14 | 8,540 |
|
Avenue Therapeutics Inc ATXI
Common Stock
|
2023-12-11 | Sell | 18,000 | $0.15 | 2,700 |
|
Avenue Therapeutics Inc ATXI
Common Stock
|
2023-12-11 | Sell | 20,000 | $0.14 | 2,800 |
|
Avenue Therapeutics Inc ATXI
Common Stock
|
2023-12-11 | Sell | 264,000 | $0.14 | 36,960 |